GWAS Research of Lung Cancer in Tianjin

NCT01255059 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-12-22

No results posted yet for this study

Summary

To study the association of Genetic Polymorphisms with Lung Cancer Risk in Tianjin Population.

Conditions

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • Chen Kexin, M.D., Ph.D · Tianjin Medical University Cancer Institute and Hospital

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2016-11-30
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01255059 on ClinicalTrials.gov